Scott Rocklage is a PhD with an excellent business and scientific background. He joined 5AM Ventures in 2003 as a Partner, and became a managing partner in 2004.
With over three decades of management and leadership experience, he is making a huge impact in the medical community. Three FDA drug approvals, and several new drug applications indicate his commitment to the industry and his craft. Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Crunchbase
His vast leadership roles include CEO and Chairman of Cubist Pharmaceuticals, Board Chairman for Relypsa, and Board Chairman of Rennovia to name several. His industry experience is quite extensive and impressive. His professional footprint is recognized throughout the industry.
Dr. Scott Rocklage also has an impressive educational background as well. He earned his Bachelor of Science degree in Chemistry from the University of California, Berkeley. He went on to achieve his PhD in Chemistry from MIT. There, he led the way in laboratory research in a Nobel Prize winner’s laboratory. His office is now in Boston, MA.
Looking back at his life, Scott Rocklage knew he wanted to achieve great things even at a young age. He also knew that it takes an education to rise to the heights. His drive to get the best grades possible, throughout his school years, paid off in helping him get into a good college.
With an education in place, commitment and opportunity, the result was a meteoric rise through the chemical industry, and venture capital later in life.
Scott’s company, 5AM Ventures commits itself to helping early-stage life science companies get off the ground. Their approach is hands-on, and they invest to build companies that will realize a successful return.
Learn more about Scott Rocklage: